Pacrinolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263130This classification denotes a beta-adrenergic blocking agent with the molecular formula C23H28N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CHE211JZXQ, chemically known as (-)-p-(3-((3,4-dimethoxyphenetyl)amino)-2-hydroxypropoxy)-beta-methylcinnamonitrile but generally known as pacrinolol, which bears US NIH Compound Identifier 6436098. European Medicines Agency schedules Pacrinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09584MIG. The term PACRINOLOL is an International Non-Proprietary Name. PACRINOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pacrinolol under HS 29269095 and SITC 51484. As of Q4 2014, PACRINOLOL remains the US FDA Preferred Term for this commodity. Pacrinolol bears US NLM identifiers UMLS ID C0135043 and NCI Concept Code C90800. SMILES: O(CC(O)CNCCC1CC(OC)C(OC)CC1)C1CCC(CC1)/C(=C/C#N)C.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.